WELCOME This newsletter includes recent news and information from NanoString Technologies and our community. NanoString and the Broad Institute Sign Three-Year Research Collaboration The collaboration is designed to explore important biological processes and new applications for the nCounter Analysis System that can be applied to improve basic and clinical research. Read More  NCI Adopts NanoString's Gene Expression Technology The National Cancer Institute (NCI) is now employing the nCounter Analysis System at two of its core labs. Read More  nCounter Virtual Gene Sets nCounter Virtual Gene Sets accelerate research by offering CodeSets with pre-selected genes and pre-designed probes. Virtual Gene Sets are made-to-order and since probes are in inventory, CodeSets can be quickly assembled and delivered. Read More  Now Available nCounter Virtual Angiogenesis Gene Set  Gene List | Product Data Sheet nCounter Virtual Apoptosis Gene Set  Gene List | Product Data Sheet nCounter Virtual Breast Cancer-Estrogen Receptor Gene Set  Gene List | Product Data Sheet nCounter Virtual Cancer Reference Gene Set  Gene List | Product Data Sheet nCounter Virtual Cell Cycle Gene Set  Gene List | Product Data Sheet nCounter Virtual Inflammation Gene Set  Gene List | Product Data Sheet nCounter Virtual Stem Cell Gene Set  Gene List | Product Data Sheet Sample Flexibility for Gene Expression Analysis with the nCounter Analysis System Learn how to achieve sensitive results from total RNA, cell lysates, tissue homogenates, whole blood lysate without globin mitigation and degraded RNA from FFPE tissue. Read More  Attenuation Strategies for Highly Expressed Genes in the nCounter Gene Expression Assay NanoString has developed a strategy that enables the study of a large set of genes, even with wide ranges of gene expression levels within the same sample. Read More  Using the nCounter Analysis System with FFPE Samples for Gene Expression Analysis Learn how the nCounter Analysis System can deliver accurate and sensitive gene expression data from purified RNA from FFPE samples and from unpurified crude FFPE extracts. Read More  A Systems View of Host Defense Nature Biotechnology, November 2009 Read More  Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses Science Express, September 2009 Read More  Evaluation of CYP1A1 and CYP2B1/2 m-RNA Induction in Rat Liver Slices Using the NanoString® Technology: A Novel Tool for Drug Discovery Lead Optimization Drug Metabolism Letters, August 2009 Read More			SCIENCE nCOUNTER In this edition of our newsletter we are profiling the winners of our recent abstract contest. Two winners were selected. Each has won a free project using the nCounter Analysis System. Susan Lindquist, Ph.D. Whitehead Institute for Biomedical Research Dr. Lindquist is working to identify and develop small molecule modifiers of protein folding and cellular stress response for the treatment of neurodegenerative disorders and cancer. Read More  Katie Lunnon, Ph.D., Simon Lovestone, Ph.D., and Angela Hodges, Ph.D. Institute of Psychiatry, King's College London This research team is working to find better predictive biomarkers for Alzheimer's Disease. Read More  Have you recently published or presented interesting work using the nCounter Analysis System? Are you planning to? Please let us know and we may feature your work on our website and/or in an upcoming newsletter! UPCOMING EVENTS Molecular Medicine Tri-Conference, San Francisco, CA February 3-5, 2010 NanoString Technologies will host a luncheon seminar during the Cancer Profiling and Pathways Program, Wednesday, February 3, 2010; 12:40-1:10PM. Room TBA. Please visit NanoString Technologies at Booth 506. View Details  American College of Medical Genetics, Albuquerque, NM March 23-28, 2010 Please visit NanoString Technologies at ACMG 2010. View Details  Please join our Facebook Group!
				www.NanoString.com
		© 2010 NanoString Technologies, Inc. All rights reserved. NanoString Technologies, NanoString nCounter, and Molecules That Count are trademarks of NanoString Technologies, Inc., in the United States and/or other countries. All other trademarks and/or service marks not owned by NanoString that appear in this document are the property of their respective owners.